The C8 MediSensors story began with a simple belief – people with diabetes deserve better. What followed was an exciting fusion of the right talent, timing, and technology laser-focused on the right mission. The talent? Three friends, experts in their individual fields, capable of tackling daunting engineering challenges. The technology? A rapid cascade of innovation already changing the world. The timing? A time when, not only was technology crossing a horizon, but the three friends were powerfully and personally motivated to find a solution – a means to measure glucose non-invasively.
When hit by a pulse of light, it will vibrate in its own pattern, generating a spectrum of colors in something known as the Raman Effect. This unique spectral flash is a snapshot that reveals how much glucose is present beneath the skin without physically drawing and testing blood.

The real beauty in this flash of light is what it means to people with diabetes – accurate, convenient, and non-invasive continuous glucose monitoring (nCGM).
It works with the power of light. A small, light-sensitive sensor is worn against the body, held securely in place with a comfortable band. The sensor transmits a safe pulse of light through the skin and identifies glucose by its unique Raman fingerprint. The glucose number is transmitted wirelessly to an easy-to-use app on an ordinary smartphone using Bluetooth technology.
Raman spectroscopy was first developed in the early 20th century, but due to the extreme difficulty of isolating the information Raman light provided, it wasn't possible to use it to measure glucose. The signal was too weak and the signal-to-noise ratio was simply too daunting. Jan Lipson and Robert McNamara had successfully overcome these challenges during their careers in the telecommunications industry and they now leveraged innovations from that field to engineer a breakthrough in glucose measurement.